Skip to Content
Merck

Enrofloxacin and Toltrazuril Are Able to Reduce

Frontiers in cellular and infection microbiology (2017-08-12)
Rafaela J da Silva, Angelica O Gomes, Priscila S Franco, Ariane S Pereira, Iliana C B Milian, Mayara Ribeiro, Paolo Fiorenzani, Maria C Dos Santos, José R Mineo, Neide M da Silva, Eloisa A V Ferro, Bellisa de Freitas Barbosa
ABSTRACT

Classical treatment for congenital toxoplasmosis is based on combination of sulfadiazine and pyrimethamine plus folinic acid. Due to teratogenic effects and bone marrow suppression caused by pyrimethamine, the establishment of new therapeutic strategies is indispensable to minimize the side effects and improve the control of infection. Previous studies demonstrated that enrofloxacin and toltrazuril reduced the incidence of

MATERIALS
Product Number
Brand
Product Description

Supelco
Toltrazuril, VETRANAL®, analytical standard